Literature DB >> 1218373

Ischaemic optic neuropathy. The clinical profile and history.

D R Boghen, J S Glaser.   

Abstract

The clinical situation of acute optic disc infarction in middle-aged and senescent patients is not uncommon, yet with the exception of those instances due to giant-cell arteritis, pathophysiological mechanisms remain obscure. In hopes of elucidating this syndrome, the clinical profile and natural history of 37 cases of non-arteritic ischaemic optic neuropathy were reviewed. For contrast, 13 cases of arteritic optic neuropathy were surveyed. The salient features of idiopathic optic neuropathy may be summarized as follows: (1) the syndrome occurs primarily in 55-70-year-old patients who, for the most part, are otherwise well; (2) mild hypertension is present in about half of the cases, but does not determine a separate variant of the disorder; (3) there is no significant association with extracranial carotid occlusive disease; (4) over long follow-up periods there appears to be no increased incidence of stroke; (5) the syndrome should be easily recognized on clinical grounds, consisting of sudden or rapidly progressive monocular visual deficit associated with optic disc swelling, with stable visual defects of variable degree; (6) after an interval of months to many years, the second eye is involved in about 40% of cases (old optic atrophy coupled with contralateral fresh disc infarction may be confused with the Foster-Kennedy syndrome); (7) no form of therapy has proved efficacious; (8) pathophysiological mechanisms remain speculative. It is the responsibility of the physician, be he ophthalmologist or neurologist, to distinguish the patient with occult arteritis (history, physical examination, sedimentation rate, arterial biopsy) and institute immediate high-dosage corticosteroid therapy. It is also incumbent upon the clinician to desist from unnecessary and unrewarding diagnostic procedures, in particular cerebral angiography, when confronted with an instance of non-arteritic ischaemic optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1218373     DOI: 10.1093/brain/98.4.689

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  42 in total

1.  Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours.

Authors:  P J Grattan-Smith; J G Morris; A O Langlands
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy.

Authors:  Corina Radoi; Tony Garcia; Catherine Brugniart; Alain Ducasse; Carl Arndt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-01       Impact factor: 3.117

3.  Changes in Visual Function over Time in Koreans with Non-arteritic Anterior Ischaemic Optic Neuropathy.

Authors:  Ji Woong Chang; Jin Choi; Young Suk Yu; Seong-Joon Kim
Journal:  Neuroophthalmology       Date:  2014-02-07

Review 4.  Optic nerve: a concise review of the anatomy, pathophysiology and principal acquired disorders.

Authors:  A Laterza; A Nappo
Journal:  Ital J Neurol Sci       Date:  1987-12

Review 5.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

Review 6.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

Review 7.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

8.  Treatmenf of optic neuritis by retrobulbar injection of triamcinolone.

Authors:  E S Gould; A C Bird; P K Leaver; W I McDonald
Journal:  Br Med J       Date:  1977-06-11

9.  Anterior ischaemic optic neuropathy: recurrent episodes in the same eye.

Authors:  R W Beck; P J Savino; N J Schatz; C H Smith; R Sergott
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

10.  Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial.

Authors:  D B Rootman; H S Gill; E A Margolin
Journal:  Eye (Lond)       Date:  2013-02-01       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.